Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/19/2025

Managing Physiological Hyperarousal

Introduction to Hyperarousal Management

  • The American Academy of Sleep Medicine recommends a combination of cognitive behavioral therapy with relaxation techniques to manage physiological hyperarousal, targeting both cognitive distortions and physical manifestations of hyperarousal 1, 2

Cognitive Behavioral Therapy (CBT)

  • Cognitive Behavioral Therapy (CBT) addresses maladaptive thoughts and behaviors that maintain hyperarousal, helping to restructure cognitive distortions into more adaptive thoughts, and is particularly effective for insomnia-related hyperarousal (CBT-I) 1, 2
  • Cognitive behavioral therapy is a recommended psychotherapeutic approach for managing anxiety in patients with RCVS 3

Relaxation Techniques

  • Progressive Muscle Relaxation is a methodical tensing and relaxing of different muscle groups that can help manage hyperarousal 2
  • Mindfulness Meditation reduces general psychophysiological arousal, according to the Annals of the Rheumatic Diseases, and is also effective for anxiety in RCVS patients 4, 5
  • Biofeedback trains patients to control physiological variables through visual or auditory feedback, as recommended by the American Academy of Sleep Medicine 2

Environmental Modifications

  • Reducing noise and bright lights can help create a sleep environment conducive to relaxation, as suggested by the Pediatrics journal 6
  • Creating a sleep environment conducive to relaxation is crucial for managing hyperarousal, according to the American Academy of Sleep Medicine 2
  • Limiting disruptions to sleep is essential for regulating physiological arousal, as recommended by the Pediatrics journal 6

Sleep Hygiene Education

  • Establishing regular sleep-wake schedules to minimize circadian dysregulation is vital for managing hyperarousal, as recommended by the American Academy of Sleep Medicine 2
  • Regular sleep patterns are recommended lifestyle modifications for managing anxiety in RCVS patients 5

Pharmacological Interventions

  • Selective Serotonin Reuptake Inhibitors (SSRIs) are effective for anxiety-related hyperarousal, according to the Journal of the American Academy of Child and Adolescent Psychiatry, but require monitoring for potential activation symptoms 7
  • Low-dose SSRIs may be helpful for globus sensation (feeling of a lump in the throat) related to hyperarousal, as reported by the Journal of Neurology, Neurosurgery and Psychiatry 8
  • Low-Dose Sedating Antidepressants, such as trazodone, mirtazapine, doxepin, and amitriptyline, can be useful when hyperarousal affects sleep, as recommended by the American Academy of Sleep Medicine 2
  • Benzodiazepine Receptor Agonists (BzRAs) can be considered for short-term management of severe hyperarousal, but require monitoring for potential adverse effects, according to the American Academy of Sleep Medicine 2
  • The American College of Cardiology suggests considering short-term benzodiazepines with careful monitoring for respiratory depression and sedation for severe anxiety in RCVS patients 9
  • Low-dose beta-blockers (e.g., propranolol) may help with physical symptoms of anxiety without affecting cerebral vasculature, but their use should be carefully considered and monitored 9

Treatment Considerations

  • Regular assessment of hyperarousal symptoms using validated tools is necessary for effective management 2
  • Adjustment of treatment plan based on response to therapy is crucial for optimal outcomes 2
  • Monitoring for side effects of medications, particularly activation symptoms with SSRIs, is essential for safe treatment 7
  • The American College of Cardiology recommends screening for anxiety using validated tools, such as the Generalized Anxiety Disorder Questionnaire-2, to assess anxiety in patients with RCVS 9
  • Assessment for comorbid depression is necessary, as it frequently coexists with anxiety in patients with RCVS 10
  • Removing precipitating factors, such as discontinuing potentially causative medications and avoiding vasoactive substances, is essential for managing RCVS 9
  • Supportive care, including bed rest and analgesics for headache management, and calcium channel blockers (nimodipine, verapamil) for RCVS symptoms, should be provided as needed 9
  • Glucocorticoids should be avoided, as they have been reported as independent predictors of worse outcomes in RCVS 9
  • Regular assessment of anxiety symptoms and monitoring for resolution of RCVS (typically within 3 months) are necessary for effective management 9
  • Neuroimaging follow-up to confirm resolution of vasoconstriction is also recommended 9

REFERENCES

2

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008